These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25735358)

  • 21. Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.
    Turkeli M; Aldemir MN; Cayir K; Simsek M; Bilici M; Tekin SB; Yildirim N; Bilen N; Makas I
    Asian Pac J Cancer Prev; 2015; 16(3):985-9. PubMed ID: 25735393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival rates and prognosis of gastric cancer using an actuarial life-table method.
    Moghimi-Dehkordi B; Safaee A; Zali MR
    Asian Pac J Cancer Prev; 2008; 9(2):317-21. PubMed ID: 18712983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution.
    Wu HL; Tian Q; Peng CW; Liu SP; Li Y
    Asian Pac J Cancer Prev; 2011; 12(12):3341-5. PubMed ID: 22471477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.
    Bertelsen CA; Neuenschwander AU; Jansen JE; Wilhelmsen M; Kirkegaard-Klitbo A; Tenma JR; Bols B; Ingeholm P; Rasmussen LA; Jepsen LV; Iversen ER; Kristensen B; Gögenur I;
    Lancet Oncol; 2015 Feb; 16(2):161-8. PubMed ID: 25555421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
    Badgwell B; Ajani J; Blum M; Ho L; Fournier K; Chiang YJ; Matamoros A; Das P; Mansfield P
    Ann Surg Oncol; 2016 Jan; 23(1):156-62. PubMed ID: 26059652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
    Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
    Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized Chemotherapy for Metastatic Gastric Cancer: Retrospective Data from a University Hospital in Brazil.
    Aguiar Junior PN; Ribas C; Forones NM
    Asian Pac J Cancer Prev; 2015; 16(13):5289-96. PubMed ID: 26225668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
    De Potter T; Flamen P; Van Cutsem E; Penninckx F; Filez L; Bormans G; Maes A; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):525-9. PubMed ID: 11914891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer.
    de Aguiar VG; Segatelli V; Macedo ALV; Goldenberg A; Gansl RC; Maluf FC; Usón Junior PLS
    Future Oncol; 2019 Feb; 15(4):401-408. PubMed ID: 30620220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term statin therapy improves oncological outcome after radical gastrectomy for stage II and III gastric cancer.
    Nam DH; Lee H; Park JC; Shin SK; Lee SK; Hyung WJ; Lee YC; Kang MW; Noh SH
    Anticancer Res; 2014 Jan; 34(1):355-61. PubMed ID: 24403487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
    Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
    World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor deposits: Prognostic significance in gastric cancer patients.
    Yildiz B; Etiz D; Dal P; Junushova B; Pasaoglu O; Yilmaz E; Erkasap S; Dincer M
    J BUON; 2016; 21(6):1476-1481. PubMed ID: 28039711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The results of treatment of gastric cancer in the Provincial Hospital in Zielona Góra].
    Siemion L; Bandurski J; Malinger S
    Przegl Lek; 2015; 72(3):120-5. PubMed ID: 26731867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
    Orsini RG; Verhoeven RH; Lemmens VE; van Steenbergen LN; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Cancer; 2015 Sep; 51(13):1675-82. PubMed ID: 26159248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of marital status on the survival of patients with gastric cancer.
    Zhou R; Yan S; Li J
    J Gastroenterol Hepatol; 2016 Apr; 31(4):768-75. PubMed ID: 26513206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment.
    Yoon SH; Kim YH; Lee YJ; Park J; Kim JW; Lee HS; Kim B
    PLoS One; 2016; 11(8):e0161278. PubMed ID: 27517841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
    Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
    Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.